Related Experiment Videos
[What can the clinician expect today from PSA determination?]
1Service d'Urologie, Hôpital Saint-Louis, Paris, France.
Nuclear Medicine and Biology
|April 1, 1994
Abstract:
Since its characterization in 1979, PSA has become an indispensable tumoral marker to justify hospitalization of patients with prostate cancer. In addition to being a standard tumor marker used to follow the course of the disease, PSA can also be used as a therapeutic indicator of prostate cancer. PSA is becoming increasingly important for this latter application.